Where do u get your info? We only want Credible grapevine resources. Pls reveal your source ? If that were 1/2 true then the leak would be out and Ligand would be much higher so I will ignore this information.
It is hard for me to convince myself that larger phar or bio firms would want to buy LGND. Their business models are completely different and it would not be efficient for a large phar firm to deal with competitors to collect future 5% royalty (and they may have competing in-house program).
That said, I think it makes sense for large firms to buy-out the right so they don't have to pay future royalty. I could imagine scenario when GSK buy out the rights of Promatca for 600M-1B after Hepartis C gets approved.
Don't worry anything that they have that is good they sell for dirt money at our expense. This stock will never be a good stock. I have had this for 15 years. My $5000 investment is worth $500. I have wondered if they take the money people invest in this company for research and development spending our money to sell their products to their parent company at a fraction of the cost.